Browse by Poster Title

• A
• P-345
  A Comparison of Data Mining Algorithms Using Different Drug Classifications for Signal Identification
  Favorite
• P-390
  A Contemporary Characterization of Patients with Non-valvular Atrial Fibrillation Starting Oral Anticoagulants in Quebec, Canada
  Favorite
• P-076
  A Controlled 1-year Mirror-image Study of the Effect of Paliperidone Palmitate on Hospitalization in the Treatment of Schizophrenia in China
  Favorite
• P-378
  A Counterfactual Approach to Minimize Channeling Bias in Post-market Safety Surveillance
  Favorite
• P-269
  A Descriptive Retrospective Cohort Study to Evaluate the Incidence of Severe COVID 19 Outcomes Among sars-cov-2 Infected Patients in the United States
  Favorite
• P-563
  A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
  Favorite
• P-101
  A Pharmacovigilance Analysis of Restless Legs Syndrome Treatments and Suicidality
  Favorite
• P-338
  A Proof of Concept Study to Test the E-CORE Network in Studying Safety and Effectiveness of Treatments in COVID-19 Patients
  Favorite
• P-117
  A Rapid Review on the Adherence to Evidence-based Medical Therapy in Peripheral Artery Disease Patients
  Favorite
• P-354
  A Retrospective Database Study to Evaluate Incidence of Influenza and Influenza-like Illness (ILI) Among Rheumatoid Arthritis (RA) Patients Taking Conventional Synthetic Disease Modifying Antirheumatic Drugs (csDMARD)
  Favorite
• P-278
  A Review of the Sampling Methodology Used in Studies Evaluating the Effectiveness of Risk Minimization Measures in Europe
  Favorite
• P-083
  A Survey of HLA-B 1502 Genotype Testing on Carbamazepine New User in a Regional Teaching Hospital in Taiwan, 2019
  Favorite
• P-275
  A Systematic Literature Review of the Epidemiology, Health-related Quality of Life and Economic Burden, Including Disease Pathways and Treatment Patterns of Relapsed/refractory Classical Hodgkin Lymphoma
  Favorite
• P-404
  A Systematic Review of Global Oncology Treatment Practice and Modifications During COVID-19
  Favorite
• P-259
  A Systematic Review of Non-small Cell Lung Cancer Treatment-related Cardiotoxicity
  Favorite
• P-365
  A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia
  Favorite
• P-220
  Absence Benefit Use and Payment Trends Among Short- and Long-term Disability, and Workers' Compensation for Employees with Any of 20 Top Agency for Healthcare Research and Quality Conditions
  Favorite
• P-227
  Absence Benefit Utilization, Duration of Leaves, and Payments Vary by Benefit and over Time for Short- and Long-term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States
  Favorite
• P-012
  Adherence to Anti-dementia Medicine: A South African Database Analysis
  Favorite
• P-086
  Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
  Favorite
• P-119
  Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
  Favorite
• P-171
  Adverse Events Associated with Remdesivir in covid-19 Patients: Evaluation of Spontaneous Reports Submitted to US FDA Adverse Event Reporting System (FAERS)
  Favorite
• P-173
  Adverse Events in covid-19 Patients Treated with Lopinavir/ritonavir: Exploration of US FDA Adverse Event Reporting System (FAERS) Reports
  Favorite
• P-229
  Adverse Events in NSCLC Patients Treated with Docetaxel Monotherapy
  Favorite
• P-342
  Adverse Events of the COVID-19 Vaccines Reported to the Vaccine Adverse Event Reporting System (VAERS), December 14, 2020 -january 22, 2021
  Favorite
• P-383
  Adverse Reactions to Dolutegravir Reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
  Favorite
• P-246
  An Evaluation of Injurious Falls and Fall-risk-increasing-drug (FRID) Prescribing Behaviors in a Nationally Representative Sample & the Pharmacist’s Role in Fall Prevention
  Favorite
• P-122
  An Evidence-based Evaluation of Clinical Medicine Use Indicators in Children
  Favorite
• P-620
  An Open algorithm to Pre-process Free Text Self-reported Medications Data in UK Biobank
  Favorite
• P-277
  An Updated Structured Review of the Epidemiology, Guidelines, and Real-world Treatment Patterns for Relapsed/refractory Primary Mediastinal Large B-cell Lymphoma
  Favorite
• P-240
  Analysis of COVID-19 Patient Experiences Reported Through Social Media
  Favorite
• P-093
  Analysis of Voluntarily Reported Medication Errors: An Excerpt from a Teaching Hospital in a Developing Country
  Favorite
• P-470
  Antibiotic Resistance Pattern and Treatment Outcomes Among Empyema Thoracis Patients: A Cross-sectional Study
  Favorite
• P-412
  Antimicrobial Resistance in Endodontic Infections in Latin America (MICROBE-DENT): Systematic Review
  Favorite
• P-237
  Antimicrobial Use in Patients Diagnosed with Chronic Kidney Disease Admitted in the Internal Medical Wards at Dr George Mukhari Academic Hospital
  Favorite
• P-251
  Anti-osteoporosis Treatment After a Major Osteoporotic Fracture Is Often Lacking
  Favorite
• P-370
  Antithrombotic Therapy Prescription Patterns in the Secondary Prevention of Stroke in Patients with Atrial Fibrillation: Findings from a Real-world, Population-based Study
  Favorite
• P-033
  Any Link Between Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-control Study
  Favorite
• P-635
  Are Biologic Medicines Getting a FAERS Go? A Case Study of Rituximab and Pyoderma Gangrenosum (PG)
  Favorite
• P-547
  Aromatase Inhibitors Associated with Sjogren’s Syndrome: A Disproportionality Analysis in Spontaneous Reporting Database
  Favorite
• P-406
  Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
  Favorite
• P-363
  Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
  Favorite
• P-081
  Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
  Favorite
• P-359
  Assessment of Antipsychotic Use and Other Predictors Associated with Mortality in Patients with Delirium: A Population-based Nested Case Control Study
  Favorite
• P-167
  Assessment of Drug Related Problems at a Tertiary Care Teaching Hospital
  Favorite
• P-478
  Assessment of Drug-drug Interactions Among Geriatric Patients in Community Setting
  Favorite
• P-241
  Assessment of Health-related Quality of Life in Adults with Asthma by Asthma Severity
  Favorite
• P-026
  Assessment of Predictors of Fractures in German Older Adults Using a Large Population Sample
  Favorite
• P-029
  Assessment of the National Pharmacovigilance System in Nepal Using the Indicator Based Pharmacovigilance Assessment Tool (IPAT)
  Favorite
• P-504
  Association Between Anticholinergic Burden of Medications and Emergency Care in the Elderly Assisted in the Brazilian Prymary Care Setting
  Favorite
• P-621
  Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients with Type 2 Diabetes
  Favorite
• P-231
  Association Between Non-adherence to Endocrine Therapy and the Risk of Recurrence Among Breast Cancer Survivors: A Systematic Literature Review
  Favorite
• P-585
  Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation
  Favorite
• P-496
  Association Between Persistence to Treatment After Percutaneous Coronary Intervention and Clinical Outcomes in Acute Coronary Syndrome Patients: A Multicenter Study in Indonesia
  Favorite
• P-386
  Association Between Primary Care Provider Payment Models and Adherence to Anticoagulation in a Sample of Patients with Atrial Fibrillation
  Favorite
• P-271
  Association Between the Multiple Myeloma Treatments and Vascular Adverse Events in Taiwanese Multiple Myeloma Patients: A Population-based Cohort Study
  Favorite
• P-007
  Association Between the Use of Mood Stabilizers and Risk of Trauma Among Patients with Bipolar Disorder
  Favorite
• P-586
  Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
  Favorite
• P-088
  Association of Inflammatory Bowel Disease with the Risk of Parkinson’s Disease: A Meta-analysis of Real-world Evidence
  Favorite
• P-399
  Association of Ondansetron Use and Subsequent Acute Kidney Injury in Critical Care
  Favorite
• P-505
  Automating Individual Case Safety Report Identification Within Scientific Literature Using Natural Language Processing
  Favorite
• P-465
  Avoidable Public Expenditures with Selected Antineoplastic Drugs for Breast Cancer in Brazil
  Favorite
• P-417
  Awareness of Pregnant Women About the Spontaneous Adverse Drug Reaction Reporting System in Bulgaria- a Pilot Study
  Favorite